Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements. 2013

Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
Section for Biologics, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark. martin.neergaard@sund.ku.dk

The purpose of this work was to explore the relation between protein-protein interactions (PPIs) and solution viscosity at high protein concentration using three monoclonal antibodies (mAbs), two of the IgG4 subclass and one of the IgG1 subclass. A range of methods was used to quantify the PPI either at low concentration (interaction parameter (kD) obtained from dynamic light scattering, DLS) or at high concentration (solution storage modulus (G') from ultrasonic shear rheology). We also developed a novel method for the determination of PPI using the apparent radius of the protein at either low or high protein concentration determined using DLS. The PPI measurements were correlated with solution viscosity (measured by DLS using polystyrene nanospheres and ultrasonic shear rheology) as a function of pH (4-9) and ionic strength (10, 50 and 150 mM). Our measurements showed that the highest solution viscosity was observed under conditions with the most negative kD, the highest apparent radius and the lowest net charge. An increase in ionic strength resulted in a change in the nature of the PPI at low pH from repulsive to attractive. In the neutral to alkaline pH region the mAbs behaved differently with respect to increase in ionic strength. Two mAbs (A and B) showed little or no effect of increasing ionic strength, whereas mAb-C showed a remarkable decrease in attractive PPI and viscosity. Previous studies have mainly investigated mAbs of the IgG₁ and IgG₂ subclass. We show here, for the first time, that mAbs of the IgG₄ subclass behave similar as the other subclasses. By comparison of the three tested mAbs with mAbs investigated in other studies a clear linear trend emerges between the pH of strongest attractive PPI and highest solution viscosity. The determination of PPI using either kD or apparent radius is thus a useful prediction tool in the determination of solution conditions that favors low solution viscosity at high protein concentration of therapeutically used mAb molecules. The novel methodology using apparent radius is a simple and rapid alternative to determine relative PPI directly under formulation conditions. The method can potentially serve as a high-throughput screening tool in formulation development.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014783 Viscosity The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Viscosities
D054118 Nanospheres Spherical particles of nanometer dimensions. Nanosphere
D025941 Protein Interaction Mapping Methods for determining interaction between PROTEINS. Interaction Mapping, Protein,Interaction Mappings, Protein,Mapping, Protein Interaction,Mappings, Protein Interaction,Protein Interaction Mappings

Related Publications

Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
January 2014, Journal of pharmaceutical sciences,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
June 2023, Molecular pharmaceutics,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
April 2013, Journal of pharmaceutical sciences,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
December 2010, Journal of pharmaceutical sciences,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
September 2009, Journal of pharmaceutical sciences,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
January 2021, mAbs,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
December 1997, Journal of immunology (Baltimore, Md. : 1950),
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
January 1983, Oncology,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
December 2025, mAbs,
Martin S Neergaard, and Devendra S Kalonia, and Henrik Parshad, and Anders D Nielsen, and Eva H Møller, and Marco van de Weert
May 2015, Pharmaceutical development and technology,
Copied contents to your clipboard!